Samil Pharmaceutical삼일제약
000520 · KOSPI · ₩000520 · 삼일제약
₩7,650▼ ₩40 (0.52%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 19, 2026Open on DART
Predicted impact: Low
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −5.3% vs sector, volume 0.7× normal (5 trading days)
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 21, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
- Results of Rights Offering or Issuance of Equity-Linked Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의발행결과(자율공시)Jun 19, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 11, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jun 11, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Jun 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 5, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Jun 2, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 1, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시May 29, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서May 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 22, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서May 20, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서May 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 6, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Apr 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 23, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 27, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Mar 25, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Mar 16, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Feb 27, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 26, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Feb 26, 2026Open on DART
- Amended: Change in revenue or profit of 30% or more[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경Jan 26, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 26, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Jan 23, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Dec 31, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 28, 2025Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Oct 23, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서May 15, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 15, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Results of Rights Offering or Issuance of Equity-Linked Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의발행결과(자율공시)Apr 16, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Samil Pharmaceutical / 삼일제약 / 000520 / KRX:000520
Source: KRX statistical information